{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T15:02:20Z","timestamp":1783090940180,"version":"3.54.6"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T00:00:00Z","timestamp":1716768000000},"content-version":"vor","delay-in-days":1091,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jacepopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACEP Open"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1002\/emp2.12456","type":"journal-article","created":{"date-parts":[[2021,5,29]],"date-time":"2021-05-29T19:40:55Z","timestamp":1622317255000},"page":"e12456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Color vision disturbances secondary to oral tranexamic acid"],"prefix":"10.1016","volume":"2","author":[{"given":"Adam S.","family":"Kiser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gena L.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan D.","family":"Napier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin T.","family":"Howington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1002\/emp2.12456_bb0010","doi-asserted-by":"crossref","first-page":"339","DOI":"10.5603\/AIT.a2015.0011","article-title":"Tranexamic acid: a clinical review","volume":"47","author":"Ng","year":"2015","journal-title":"Anaesthesiol Intensive Ther"},{"key":"10.1002\/emp2.12456_bb0015","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/anae.12910","article-title":"The current place of tranexamic acid in the management of bleeding","volume":"70","author":"Hunt","year":"2015","journal-title":"Anaesthesia"},{"issue":"5","key":"10.1002\/emp2.12456_bb0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"},{"issue":"7","key":"10.1002\/emp2.12456_bb0025","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1177\/1076029616670257","article-title":"Factor VII deficiency: from basics to clinical laboratory diagnosis and patient management","volume":"23","author":"Sevenet","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"issue":"4","key":"10.1002\/emp2.12456_bb0030","doi-asserted-by":"crossref","DOI":"10.3390\/jcm6040038","article-title":"Factor VII deficiency: clinical phenotype, genotype and therapy","volume":"6","author":"Napolitano","year":"2017","journal-title":"J Clin Med"},{"key":"10.1002\/emp2.12456_bb0035","series-title":"Tranexamic Acid Injection [package insert]","year":"2019"},{"key":"10.1002\/emp2.12456_bb0040","series-title":"Tranexamic Acid Tablet [package insert]","year":"2019"},{"issue":"6","key":"10.1002\/emp2.12456_bb0045","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/0002-9394(88)90069-4","article-title":"Retinal artery occlusion associated with tranexamic acid therapy","volume":"105","author":"Parsons","year":"1988","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"10.1002\/emp2.12456_bb0050","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1097\/00006982-199001030-00005","article-title":"Central venous stasis retinopathy following the use of tranexamic acid","volume":"10","author":"M","year":"1990","journal-title":"Retina"},{"issue":"4","key":"10.1002\/emp2.12456_bb0055","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s10157-003-0254-y","article-title":"Tranexamic acid\u2010induced visual impairment in a hemodialysis patient","volume":"7","author":"Kitamura","year":"2003","journal-title":"Clin Exp Nephrol"},{"issue":"6","key":"10.1002\/emp2.12456_bb0060","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1097\/00000542-200612000-00029","article-title":"Antifibrinolytic therapy use to mitigate blood loss during staged complex major spine surgery: postoperative visual color changes after tranexamic acid administration","volume":"105","author":"Cravens","year":"2006","journal-title":"Anesthesiology"}],"container-title":["JACEP Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12456","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/emp2.12456","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224011627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2688115224011627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/emp2.12456","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,25]],"date-time":"2025-01-25T02:04:54Z","timestamp":1737770694000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2688115224011627"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2688115224011627"],"URL":"https:\/\/doi.org\/10.1002\/emp2.12456","relation":{},"ISSN":["2688-1152"],"issn-type":[{"value":"2688-1152","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Color vision disturbances secondary to oral tranexamic acid","name":"articletitle","label":"Article Title"},{"value":"JACEP Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1002\/emp2.12456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 THE AUTHORS. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"e12456"}}